Premium
Clinically atypical cutaneous mycobacteriosis: A therapeutic challenge
Author(s) -
RódenasHerranz Teresa,
LinaresGonzalez Laura,
MuñozMedina Leopoldo,
RuizVillaverde Ricardo
Publication year - 2020
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.14184
Subject(s) - medicine , tuberculosis , mycobacterium tuberculosis , incidence (geometry) , dermatology , mycobacterium infections , mycobacterium , cutaneous tuberculosis , intensive care medicine , pathology , physics , optics
Mycobacterium caprae , a member of the Mycobacterium tuberculosis complex, causes tuberculosis in humans and animals, but the incidence in humans is very low worldwide. Direct contact with animals and with unpasteurized dairy products is the most frequent source of contagion. Cutaneous tuberculosis supposes a diagnostic challenge due to its variety of clinical manifestations and the difficulty in demonstrating resistant acid‐alcohol bacilli in histological samples. In cases of high suspicion, the initiation of antituberculosis treatment should be considered empirically. Combined therapeutic regimens are necessary to prevent long‐term resistance and complications, although the duration of treatment has not been fully established.